Biodexa Pharmaceuticals (BDRX)
NASDAQ: BDRX
· Real-Time Price · USD
6.70
0.03 (0.45%)
At close: Oct 03, 2025, 3:59 PM
6.81
1.64%
After-hours: Oct 03, 2025, 04:10 PM EDT
Biodexa Pharmaceuticals Balance Sheet Statement
Financials in GBP. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 | Q4 2022 | Q2 2022 | Q4 2021 | Q2 2021 |
| Period Ending | Jun 30, 2025 | Dec 31, 2024 | Jun 30, 2024 | Dec 31, 2023 | Jun 30, 2023 | Dec 31, 2022 | Jun 30, 2022 | Dec 31, 2021 | Jun 30, 2021 |
Cash & Equivalents | 4.04M | 1.67M | 5.05M | 5.97M | 5.23M | 2.84M | 6.42M | 10.06M | 4.2M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | n/a | n/a | n/a | n/a | -698K | -837K | -993K | -1.15M | -1.25M |
Receivables | 4.49M | 715K | 1.92M | 704K | 2.04M | 329K | 1.24M | 33K | 1.4M |
Inventory | n/a | n/a | n/a | n/a | -1.13M | n/a | n/a | n/a | n/a |
Other Current Assets | 462K | n/a | 547K | n/a | n/a | n/a | 1.02M | n/a | 1.42M |
Total Current Assets | 8.99M | 8.81M | 7.52M | 7.03M | 7.26M | 4.69M | 8.69M | 11.76M | 7.03M |
Property-Plant & Equipment | 187K | 324K | 436K | 571K | 693K | 831K | 993K | 1.15M | 1.25M |
Goodwill & Intangibles | 5.64M | 5.65M | 6.01M | 2.94M | 5K | 6K | n/a | n/a | n/a |
Total Long-Term Assets | 5.83M | 5.97M | 6.44M | 3.51M | 698K | 837K | 993K | 1.15M | 1.25M |
Total Assets | 14.82M | 14.78M | 13.97M | 10.54M | 7.96M | 5.53M | 9.68M | 12.91M | 8.28M |
Account Payables | 1.41M | 707K | 1.69M | 314K | 1.75M | 339K | 1.28M | 485K | 2.04M |
Deferred Revenue | n/a | 1.47M | n/a | 926K | n/a | 197K | n/a | n/a | n/a |
Short-Term Debt | 501K | 430K | 174K | n/a | n/a | n/a | n/a | n/a | n/a |
Other Current Liabilities | 564K | 921K | 1.44M | 3.3M | 364K | 583K | 198K | 664K | 1.67M |
Total Current Liabilities | 2.48M | 5.03M | 3.48M | 5.57M | 2.28M | 1.9M | 1.65M | 1.84M | 3.84M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 909K | 1.31M | 1.55M | n/a | -294 | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 909K | 1.42M | 1.76M | 295K | 379.71K | 463K | 546K | 620K | 682K |
Total Liabilities | 3.39M | 6.46M | 5.24M | 5.86M | 2.66M | 2.36M | 2.19M | 2.46M | 4.52M |
Total Debt | 501K | 727K | 382K | 464K | 544K | 624K | 546K | 620K | 682K |
Book Value | 11.44M | 8.32M | 8.73M | 4.68M | 5.3M | 3.16M | 7.49M | 10.45M | 3.75M |
Book Value Per Share | 5.72M | 134.33 | 3.52K | 155.93K | 757.04K | 3.16M | 7.49M | 10.45M | 3.75M |
Common Stock | 61.56K | 6.69M | 3.63M | 1.19M | 277.97K | 1.11M | 98K | 98K | 63K |
Retained Earnings | -154.13M | -150.42M | -147.88M | -144.77M | -138.97M | -135.34M | -130.76M | -127.8M | -125.55M |
Comprehensive Income | 67.77M | 53M | 61.74M | 53M | 53M | 53M | 54.72M | 54.72M | 54.72M |
Shareholders Equity | 11.44M | 8.32M | 8.73M | 4.68M | 5.3M | 3.16M | 7.49M | 10.45M | 3.75M |
Total Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |